Ardent Health Shares Plunge 33% Following Revenue Adjustment Over Receivables

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Ardent Health shares plunged 33% after revealing a $43 million revenue adjustment due to overstated receivables. A securities fraud lawsuit was filed over misleading accounting disclosures.

Ardent Health Shares Plunge 33% Following Revenue Adjustment Over Receivables

Ardent Health Services (NYSE:ARDT) experienced a significant stock decline after disclosing material accounting changes related to accounts receivable reserves. The company revealed that it had previously overstated the collectability of receivables by employing a simplified 180-day reserve methodology rather than the more rigorous historical collection analysis it had previously represented to investors.

The accounting correction resulted in a $43 million revenue adjustment and prompted the company to increase professional liability insurance reserves by $54 million. These charges reflect both the direct impact of the accounting restatement and anticipated costs related to potential litigation exposure stemming from the disclosure.

A securities fraud class action lawsuit has been initiated against the company. Investors who held shares during the relevant period and sustained losses are being notified of their rights under the pending litigation. The case centers on allegations that the company's prior disclosures regarding its accounts receivable accounting methodology were materially misleading.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 21

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN
GlobeNewswire Inc.

Immutep Faces Class Action Over $IMMP Trial Failure; Investors Have Days to Join Lawsuit

Immutep faces class action lawsuit alleging investor deception over TACTI-004 trial failure. Stock plunged 83% after March discontinuation announcement, despite positive January guidance. Lead plaintiff deadline: July 6, 2026.

IMMP